Dr. Pritchett is an Assistant Professor of Medicine and Oncology at the Mayo Clinic. He serves his patients as a community oncologist & hematologist. His research is centered on the design and implementation of innovative models of cancer care delivery, with a focus on bridging the divide for cancer patients experiencing barriers in access to care – particularly rural populations. He is the founder and medical director of Mayo Clinic’s “DEFeNDR” program – a remote patient monitoring (RPM) system that leverages digital health to facilitate outpatient management for cancer patients experiencing neutropenic fever. In September 2025, he and Dr. Jonathan Ticku launched Mayo Clinic Health System’s bispecific antibody step-up dosing program, which leverages RPM to enable access to these therapies for community-based patients and practice settings.
